Status:
COMPLETED
A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.
Lead Sponsor:
Pfizer
Conditions:
Candidiasis
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
This is a study to investigate the safety and efficacy of voriconazole for the treatment of candidemia in critically ill non-neutropenic patients
Eligibility Criteria
Inclusion
- Patients with candidemia
Exclusion
- Neutropenia
Key Trial Info
Start Date :
September 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2003
Estimated Enrollment :
412 Patients enrolled
Trial Details
Trial ID
NCT00163111
Start Date
September 1 1998
End Date
May 1 2003
Last Update
April 26 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.